# Neuroprotection in Acute Ischemic Stroke

> **NCT03320018** · PHASE2,PHASE3 · COMPLETED · sponsor: **Stony Brook University** · enrollment: 15 (actual)

## Conditions studied

- Stroke, Ischemic

## Interventions

- **DRUG:** Hydrogen
- **DRUG:** Minocycline
- **OTHER:** Placebo Hydrogen
- **OTHER:** Placebo Minocycline

## Key facts

- **NCT ID:** NCT03320018
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-02
- **Primary completion:** 2019-08-13
- **Final completion:** 2019-08-13
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03320018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03320018, "Neuroprotection in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03320018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*